SCHEMBL104886

SCHEMBL104886

CC(C)CCCCCCC(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.67
TRPV1 Q8NER1 1/20 0.40
TRPA1 O75762 1/20 0.40
KDM4C Q9H3R0 2/20 0.38
KDM4A O75164 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
BLM P54132 1/20 0.38
HIF1A Q16665 1/20 0.35
EPAS1 Q99814 1/20 0.35
OPRM1 P35372 1/20 0.35
SPHK1 Q9NYA1 1/20 0.33
TSHR P16473 1/20 0.33
CA1 P00915 1/20 0.33
FUT7 Q11130 1/20 0.32
PTPN1 P18031 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20530387 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL21925059 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL105972 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL16097135 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL7580335 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL11723029 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL11207754 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL108076 0.95 LMNA (0.71) LMNATRPV1TRPA1KDM4CKDM4A
Water SCHEMBL4955769 0.91 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL42290 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
EP-0666787-A4 COMPOSITIONS AND METHODS FOR REPAIRING PLASTIC SURFACES. CLEARFIX CORP (US) 1995-08-30 EP claimed
EP-0666787-A1 COMPOSITIONS AND METHODS FOR REPAIRING PLASTIC SURFACES CLEARFIX CORPORATION (US) 1995-08-16 EP claimed
US-5334335-A Solid polish, water and organic solvent CLEARFIX CORPORATION (US) 1994-08-02 US claimed
WO-1994008756-A1 COMPOSITIONS AND METHODS FOR REPAIRING PLASTIC SURFACES CLEARFIX CORPORATION (US) 1994-04-28 WO claimed
JP-7300593-A None JP disclosed
US-12429483-B2 System and method for determining onset and disease progression RESPIRATION SCAN LTD (IL) 2025-09-30 US disclosed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
US-20240425893-A1 RAPID PRETREATMENT Apalta Patents OÜ (EE) 2024-12-26 US disclosed
EP-4164481-B1 A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH NANOSE MEDICAL LTD (IL) 2024-10-16 EP disclosed
JP-H07300593-A ODORLESS LIQUID FUEL FOR OPEN FLAME OIL COOKER IDEMITSU PETROCHEM CO LTD 1995-11-14 JP disclosed
US-5334335-A Solid polish, water and organic solvent CLEARFIX CORPORATION (US) 1994-08-02 US disclosed
EP-0312270-B1 Antiperspirant creams and manufacture thereof PROCTER & GAMBLE (US) 1994-02-02 EP disclosed
WO-1992000948-A1 INHIBITORS OF RETROVIRAL PROTEASES SMITHKLINE BEECHAM CORPORATION (US) 1992-01-23 WO disclosed
US-4419518-A VASODILATION, HYPOTENSIVE AGENTS TOKYO TANABE CO. L.T.D. (JP) 1983-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA LMNA 3717/4885TRPV1 3969/4885TRPA1 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.